Lipid lowering for primary prevention

被引:41
作者
Yusuf, Salim [1 ]
Lonn, Eva
Bosch, Jackie
机构
[1] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, Canada
关键词
C-REACTIVE PROTEIN; HEART-FAILURE; CARDIOVASCULAR-DISEASE; ROSUVASTATIN; MORTALITY; EVENTS; TRIAL;
D O I
10.1016/S0140-6736(09)60357-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1152 / 1155
页数:4
相关论文
共 12 条
[1]   Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins [J].
Baigent, C ;
Keech, A ;
Kearney, PM ;
Blackwell, L ;
Buck, G ;
Pollicino, C ;
Kirby, A ;
Sourjina, T ;
Peto, R ;
Collins, R ;
Simes, J .
LANCET, 2005, 366 (9493) :1267-1278
[2]  
Freeman DJ, 2001, CIRCULATION, V103, P357
[3]   Rosuvastatin in older patients with systolic heart failure [J].
Kjekshus, John ;
Apetrei, Eduard ;
Barrios, Vivencio ;
Boehm, Michael ;
Cleland, John G. F. ;
Cornel, Jan H. ;
Dunselman, Peter ;
Fonseca, Candida ;
Goudev, Assen ;
Grande, Peer ;
Gullestad, Lars ;
Hjalmarson, Ake ;
Hradec, Jaromir ;
Janosi, Andras ;
Kamensky, Gabriel ;
Komajda, Michel ;
Korewicki, Jerzy ;
Kuusi, Timo ;
Mach, Francois ;
Mareev, Vyacheslav ;
McMurray, John J. V. ;
Ranjith, Naresh ;
Schaufelberger, Maria ;
Vanhaecke, Johan ;
van Veldhuisen, Dirk J. ;
Waagstein, Finn ;
Wedel, Hans ;
Wikstrand, John .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (22) :2248-2261
[4]   Narrative review: Assessment of C-reactive protein in risk prediction for cardiovascular disease [J].
Lloyd-Jones, Donald M. ;
Liu, Kiang ;
Tian, Lu ;
Greenland, Philip .
ANNALS OF INTERNAL MEDICINE, 2006, 145 (01) :35-42
[5]   Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide - Biomarkers for mortality in a large community-based cohort free of heart failure [J].
McKie, PM ;
Rodeheffer, RJ ;
Cataliotti, A ;
Martin, FL ;
Urban, LH ;
Mahoney, DW ;
Jacobsen, SJ ;
Redfield, MM ;
Burnett, JC .
HYPERTENSION, 2006, 47 (05) :874-880
[6]  
McMurray J, 2008, CIRCULATION, V118, pS711
[7]   Primary Prevention of Cardiovascular Mortality and Events With Statin Treatments [J].
Mills, Edward J. ;
Rachlis, Beth ;
Wu, Ping ;
Devereaux, Philip J. ;
Arora, Paul ;
Perri, Dan .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (22) :1769-1781
[8]   Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein [J].
Ridker, Paul M. ;
Danielson, Eleanor ;
Fonseca, Francisco A. H. ;
Genest, Jacques ;
Gotto, Antonio M., Jr. ;
Kastelein, John J. P. ;
Koenig, Wolfgang ;
Libby, Peter ;
Lorenzatti, Alberto J. ;
MacFadyen, Jean G. ;
Nordestgaard, Borge G. ;
Shepherd, James ;
Willerson, James T. ;
Glynn, Robert J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (21) :2195-2207
[9]   Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis [J].
Rossebo, Anne B. ;
Pedersen, Terje R. ;
Boman, Kurt ;
Brudi, Philippe ;
Chambers, John B. ;
Egstrup, Kenneth ;
Gerdts, Eva ;
Gohlke-Barwolf, Christa ;
Holme, Ingar ;
Kesaniemi, Y. Antero ;
Malbecq, William ;
Nienaber, Christoph A. ;
Ray, Simon ;
Skjaerpe, Terje ;
Wachtell, Kristian ;
Willenheimer, Ronnie .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (13) :1343-1356
[10]   Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial [J].
Tavazzi, Luigi ;
Maggioni, Aldo P. ;
Marchioli, Roberto ;
Barlera, Simona ;
Franzosi, Maria Grazia ;
Latini, Roberto ;
Lucci, Donata ;
Nicolosi, Gian Luigi ;
Porcu, Maurizio ;
Tognoni, Gianni .
LANCET, 2008, 372 (9645) :1231-1239